BioSpace News Archive

Press Releases

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

April 7, 2025
·
7 min read
Press Releases

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

April 7, 2025
·
14 min read
Press Releases

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025

April 7, 2025
·
1 min read
Press Releases

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025

April 7, 2025
·
4 min read
Press Releases

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

April 7, 2025
·
10 min read
Press Releases

QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

April 7, 2025
·
5 min read
Press Releases

MaaT Pharma Announces Initiation of Coverage of its Stock by H.C. Wainwright & Co

April 7, 2025
·
2 min read
European Commission approves Johnson & Johnson’s subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility

April 7, 2025
·
14 min read
Press Releases

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention

April 7, 2025
·
4 min read
Press Releases

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

April 7, 2025
·
8 min read